Babyak M, Blumenthal JA, Herman S et al. Exercise Treatment for Major Depression: Maintenance of Therapeutic Benefit at 10 Months. Psychosom Med 2000 62: 633-638.
Boman B. L-tryptophan. A rational antidepressant and a natural hypnotic? Aust NZ J Psychiatry 1988; 22: 83-97.
Byerley WF, Judd LL, Reimherr FW et al. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects. J Clin Psychopharmachol 1987;7: 127-37.
Cott JM, Fugh-Berman A. Is St. John's wort (Hypericum perforatum) an effective antidepressant? J Nerv Ment Dis. 1998;186(8):500-1.
De Smet PAG, Nolen W. St. Johns wort as an antidepressant. Br Med J 1996; 313: 241-42.
Dimeo F, Bauer M, Varahram I, et al. Benefits from aerobic exercise in patients with major depression: a pilot study. Br J Sports Med 2001;35(2):114-17.
Green P, Gispan-Herman I, Yadid Y. Increased arachidonic acid concentration in the brain of Flinders Sensitive Line rats, an animal model of depression. Journal of Lipid Research 2005;46: 1093-96.
Harrer G, Schulz V. Clinical investigation of the antidepressant effectiveness of hypericum. J Geriatr Psychiatry Neurol 1994; 7 (suppl 1): S6-8.
Horrobin PM. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002; 59(10): 913-9.
Iñiguez SD, Warren BL, Parise EM, et al. Nicotine Exposure During Adolescence Induces a Depression-Like State in Adulthood. Neuropsychopharmacology 2009;34(6):1609-24.
Jazayeri S, Tehrani-Doost M, Keshavarz SA, et al. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Australian and New Zealand Journal of Psychiatry 2008;42(3):192-98.
Kiecolt-Glaser JK, Belury MA, Porter K, et al. Depressive Symptoms, omega-6:omega-3 Fatty Acids, and Inflammation in Older Adults. Psychosomatic Medicine 2007;69(3):217-24.
Lin PY, SU KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 2007; 68:1056-1061.
Logan AC. Omega-3 fatty acids and major depression: A primer for the mental health professional. Lipids in Health and Disease 2004, 3:25.
Maratos AS, Gold C, Wang X, Crawford MJ. Music therapy for depression. Cochrane Database of Systematic Reviews 2008, Issue 1.
Morazzoni P, Bombardelli E. Hypericum perforatum. Fitoterapia 1995; 66: 43-68.
Morris MJ, Na ES, Johnson AL. Salt craving: the psychobiology of pathogenic sodium intake. Physiol Behav 2008;94(5):709-21.
Raeder MB, Steen VM, Vollset SE, Bjelland I. Associations between cod liver oil use and symptoms of depression: The Hordaland Health Study. Journal of Affective Disorders 2007;101(1-3): 245-49.
Sano I. L-5-hydroxytryptophan therapy. Folia Psychiatr Neurol Japan 1972; 26: 7-17.
Sanacora G, MD, Gueorguieva R et al. Subtype-Specific Alterations of Gamma-Aminobutyric Acid and Glutamate in Patients With Major Depression. Arch Gen Psychiatry. 2004; 61:705-713.
Sandyk R L-Tryptophan in neuro psychiatric disorders, a review. Int. J. Neuroscience 1992; 67:24-144.
Tiemeier H, van Tuijl HR, Hofman A. et al. Plasma Fatty Acid Composition and Depression are Associated in the Elderly: The Rotterdam Study" American Journal of Clinical Nutrition 2003; Vol.78, No. 1: 40-46.
van Hiele JJ. L-5-hydroxytryptyphan in depression: the first substitution therapy in psychiatry? Neuropsychobiology 1980; 6: 230-240.
van Praag HM. Central monoamine metabolism in depressions. Serotonin and related compounds. Compr Psychiatry 1980; 21: 30-43.
Volker D, et al. Depression: Does nutrition have an adjunctive treatment role? Nutrition & Dietetics 2006; 63(4):213.
Whang W, Kubzansky LD, Kawachi I, et al. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol. 2009;53(11):950-8.
